Reiterative Survival Analyses of Total Therapy 2 for Multiple Myeloma Elucidate Follow-Up Time Dependency of Prognostic Variables and Treatment Arms

PURPOSE: In Total Therapy 2, after randomly assigning 323 patients with myeloma to thalidomide and 345 to a control arm, no difference was observed in overall survival, with a median follow-up of 42 months, although at 72 months, survival was superior on the thalidomide arm in the one third exhibiti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barlogie, Bart, Anaissie, Elias, van Rhee, Frits, Shaughnessy, John D., Szymonifka, Jackie, Hoering, Antje, Petty, Nathan, Crowley, John
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903335/
https://ncbi.nlm.nih.gov/pubmed/20479421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.4465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados